| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |